Conducting Plant Material R&D? Nagoya Pact Requires ABS Due Diligence
This article was originally published in The Rose Sheet
Executive Summary
The Nagoya Protocol on Access and Benefit Sharing comes into force this fall, as will an EU regulation instituting checks to ensure that firms conducting R&D on genetic resources are compliant with ABS laws in provider countries. With other countries around the globe developing their own legislation under the international treaty, cosmetics firms large and small must exercise due diligence, assessing their ingredient use and supply chains to avoid penalties and reputational damage.
You may also be interested in...
Cosmetics Industry Vulnerable As Nagoya Protocol Enters Into Force
Launching in October, the Nagoya Protocol on Access and Benefit Sharing and related legislation emerging around the globe will focus regulatory scrutiny on companies researching and developing plants and other genetic resources for commercial applications. The cosmetics industry could be a ready target, an expert says, urging firms to assess their supply chains and ensure that necessary ABS agreements are in place.
Global Biodiversity Pact’s Potential Impact On Personal Care Still Unclear
Six months after the adoption of the Nagoya Protocol – an international treaty conceived to help ensure fairness in the way genetic resources are mined for research and development purposes – the extent to which the personal-care industry will be impacted is still not entirely clear.
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.